STAT December 4, 2023
The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we should act immediately. But a new Food and Drug Administration policy could delay things for children who need treatment now.
Many childhood cancers are still treated with intensive chemotherapies developed decades ago that leave virtually all survivors with severe or life-threatening conditions such as hearing loss, heart disease, or secondary cancers later in life. This is the unavoidable nature of these old therapies, and it’s been one of the defining paradoxes of my 20-year career in pediatric oncology: The very treatments I give children...
Today's Sponsors
Today's Sponsor